About Us

Cipla was established in 1935 with the vision of making India self-reliant and self-sufficient in healthcare. Today, we are one of the world's largest generic pharmaceutical companies with a presence in over 170 countries. We are renowned for making affordable, world-class medicines that meet the needs of patients across therapies. We also offer services like consulting, commissioning, plant engineering, technical know-how transfer and support.








Incorporated : 1935
Corporate Office : Cipla Ltd., Mumbai Central, Mumbai 400 008, India
Chairman and MD : Dr. Yusuf K. Hamied
Joint Managing Director : Mr. M.K. Hamied
Listing : BSE Limited, National Stock Exchange (NSE), Luxembourg   Stock Exchange
Turnover* : USD 1.4 billion
Employees* : 20,000
Contact : contactus@cipla.com / +91 22 23082891,
+91 22 23095521

Approvals:
US FDA, WHO-Geneva, MHRA-UK, TGA-Australia, SUKL-Slovak Republic, APVMA-Australia, MCC-South Africa, PIC-Germany, Danish Medical Agency, ANVISA-Brazil, INVIMA- Colombia, NDA-Uganda, Department of Health-Canada and MOH-Saudi Arabia, among others.